Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label trial to determine blood ethanol concentration in children receiving IMP for acute bronchitis
2009-014904-73Phase 4Terminated
- Sponsor
- Cassella-med
- Start
- Dec 2009
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Bronchicum Elixir in acute bronchitis, sponsored by Cassella-med. Primary endpoint: Blood ethanol concentration under repeated IMP dosing. Started Dec 2009; status: terminated.
02
Drugs
Bronchicum Elixir
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on 2009-014904-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014904-73.